Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials. / Jorde, Rolf; Witham, Miles; Janssens, Wim; Rolighed, Lars; Borchhardt, Kyra; de Boer, Ian H.; Grimnes, Guri; Hutchinson, Moira S.
In: Scandinavian Journal of Infectious Diseases, Vol. 44, No. 2, 02.2012, p. 126-132.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials
A1 - Jorde,Rolf
A1 - Witham,Miles
A1 - Janssens,Wim
A1 - Rolighed,Lars
A1 - Borchhardt,Kyra
A1 - de Boer,Ian H.
A1 - Grimnes,Guri
A1 - Hutchinson,Moira S.
AU - Jorde,Rolf
AU - Witham,Miles
AU - Janssens,Wim
AU - Rolighed,Lars
AU - Borchhardt,Kyra
AU - de Boer,Ian H.
AU - Grimnes,Guri
AU - Hutchinson,Moira S.
PY - 2012/2
Y1 - 2012/2
N2 - <p>Background: Vitamin D deficiency has been associated with a number of diseases, including influenza. Whether or not this reflects a causal relationship is unknown. We therefore wanted to examine if supplementation with vitamin D would affect the incidence and severity of influenza-like disease. Methods: Questionnaires on influenza were sent to subjects participating in ongoing placebo-controlled intervention studies with vitamin D supplementation, up until the end of April 2010. Results: Five hundred and sixty-nine subjects from 10 different clinical trials were included in the study, of whom 289 were randomized to receive vitamin D (1111-6800 IU/day) and 280 to receive placebo. Influenza-like disease during the previous fall/winter was reported in 38 subjects in the vitamin D group and 42 in the placebo group (non-significant), of whom 25 and 26 subjects, respectively, fulfilled our clinical criteria for influenza. In these latter subjects, the duration of illness was significantly longer among those in the vitamin D group than among those in the placebo group (median 7 (range 2-60) days vs median 4 (range 2-18) days; p = 0.007). However, this difference was not statistically significant if all 38 (vitamin D) and 42 (placebo) subjects who reported symptoms were included. Conclusion: Our results do not support the hypothesis that high doses of vitamin D supplementation will have a pronounced effect on influenza-like disease in populations not targeted for high influenza risk.</p>
AB - <p>Background: Vitamin D deficiency has been associated with a number of diseases, including influenza. Whether or not this reflects a causal relationship is unknown. We therefore wanted to examine if supplementation with vitamin D would affect the incidence and severity of influenza-like disease. Methods: Questionnaires on influenza were sent to subjects participating in ongoing placebo-controlled intervention studies with vitamin D supplementation, up until the end of April 2010. Results: Five hundred and sixty-nine subjects from 10 different clinical trials were included in the study, of whom 289 were randomized to receive vitamin D (1111-6800 IU/day) and 280 to receive placebo. Influenza-like disease during the previous fall/winter was reported in 38 subjects in the vitamin D group and 42 in the placebo group (non-significant), of whom 25 and 26 subjects, respectively, fulfilled our clinical criteria for influenza. In these latter subjects, the duration of illness was significantly longer among those in the vitamin D group than among those in the placebo group (median 7 (range 2-60) days vs median 4 (range 2-18) days; p = 0.007). However, this difference was not statistically significant if all 38 (vitamin D) and 42 (placebo) subjects who reported symptoms were included. Conclusion: Our results do not support the hypothesis that high doses of vitamin D supplementation will have a pronounced effect on influenza-like disease in populations not targeted for high influenza risk.</p>
KW - H1N1
KW - influenza
KW - randomized clinical trial
KW - vitamin D
KW - RESPIRATORY-TRACT INFECTION
KW - YOUNG FINNISH MEN
KW - 25-HYDROXYVITAMIN-D
KW - ASSOCIATION
KW - RISK
U2 - 10.3109/00365548.2011.621446
DO - 10.3109/00365548.2011.621446
M1 - Article
JO - Scandinavian Journal of Infectious Diseases
JF - Scandinavian Journal of Infectious Diseases
SN - 0036-5548
IS - 2
VL - 44
SP - 126
EP - 132
ER -